Bloomberg Markets: Sangamo, Pfizer Partner in Drug Development

Published: May 19, 2017, 8:15 p.m.

Bloomberg Markets with Carol Massar and Cory Johnson. GUEST: Alexander Macrae CEO Sangamo Therapeutics Discussing teaming with Pfizer in the development of gene therapy programs for Hemophilia.